| Literature DB >> 36017475 |
Phornsawat Baipaywad1,2, Naeun Ryu2, Soo-Seok Im3, Ukjae Lee2, Hyung Bin Son2, Won Jong Kim3, Hansoo Park2.
Abstract
Carbon-based nanomaterials, such as carbon nanotubes, fullerenes, nanodiamonds, and graphene, have been investigated for various biomedical applications, including biological imaging, photothermal therapy, drug/gene delivery, cancer therapy, biosensors, and electrochemical sensors. Graphene oxide (GO) has unique physicochemical properties and can be used to restore conductivity through oxidation. In this study, we developed poly(N-isopropylacrylamide) (PNIPAM)-based nanogel systems containing GO for controlled in vitro drug delivery. The photothermal effects of the PNIPAM/GO- and PNIPAMAAM/GO-based nanogel systems were enhanced. The release of DOX from the PNIPAM/GO-based nanogel was achieved using the photothermal effect of near-infrared irradiation. Using a Cell Counting Kit-8 assay, the cytotoxicity of all conditions demonstrated that the PNIPAM composite-based nanogels were biocompatible with no significance.Entities:
Keywords: Poly(N-isopropylacrylamide); chemotherapy; graphene oxide; nanogel; photothermal therapy
Year: 2022 PMID: 36017475 PMCID: PMC9397426 DOI: 10.1080/15685551.2022.2111854
Source DB: PubMed Journal: Des Monomers Polym ISSN: 1385-772X Impact factor: 3.718
Scheme 1.Molecular structures of NIPAM, BIS, AAM, and GO, (a) the synthesis procedure of nanogel homopolymer and hybrid nanogel using conventional radical polymerization methods and (b) the formation of nanogel.
Dynamic light scattering measurement and ζ-potential results of the PNIPAM-based nanogels.
| Sample | 25°C | 37°C | ζ-potential | |||
|---|---|---|---|---|---|---|
| Size(nm) | PDI | Size(nm) | PDI | |||
| PNIPAM | 471 | 0.30 | 173 | 0.05 | −0.83 | |
| PNIPAM/GO | 297 | 0.58 | 144 | 0.25 | −10.3 | |
Figure 1.Morphologies of PNIPAM hybrid-based nanogels (a) PNIPAM and (b) PNIPAM/GO.
Figure 2.(a) Cytotoxicity of PNIPAM-based nanogels. Human adipose-derived stem cells were treated with 100 µg of PNIPAM and PNIPAM/GO and the cytotoxicity was determined using a CCK-8 assay. (b) Confocal microscopic images of the cells after incubation with PNIPAM/GO-loaded RhB fluorescence nanoparticles at 37 °C for 24 h. Red denotes nanoparticles and blue denotes nuclei. NC: negative control; RhB: rhodamine B.
Figure 3.(a) The role of drug release from PNIPAM-based nanogels upon change in temperature, (b) DOX release profile from PNIPAM/GO-based nanogel in vitro, (c) Cytotoxicity of PNIPAM/GO-based nanogel. Breast cancer cells (MDA-MB-231) were treated with loaded DOX in PNIPAM/GO-based nanogel (p < 0.05), (d) Confocal microscopic images of MDA-MB-231 cells after incubation with PNIPAM/GO-loaded DOX fluorescence nanoparticles at 37 °C for 24 h. Red denotes nanoparticles and blue denotes nuclei. D: diameter. LCST: lower critical solution temperature. NPs: nanoparticles. DOX: doxorubicin.
Figure 4.(a) Size averages based on temperature. (b) ζ-potentials of PNIPAM hybrid-based nanogels.
Figure 5.(a) Raman spectra of hybrid PNIPAM-based nanogels, where D and G denote the characteristic D and G bands of graphene, respectively. (b) The photothermal effects of hybrid PNIPAM-based nanogels.